Join to View Full Profile
6535 N Charles StSte 400Baltimore, MD 21204
Phone+1 410-828-7417
Fax+1 410-828-4695
Dr. Levin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Ohio State University HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1980
- MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 1977 - 1978
- St Mary's Hospital (Waterbury)Residency, Internal Medicine, 1975 - 1977
- Yale-New Haven Medical CenterInternship, Transitional Year, 1974 - 1975
- University of Maryland School of MedicineClass of 1974
Certifications & Licensure
- MD State Medical License 1975 - 2026
- OH State Medical License 1979 - 1982
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- Initiating Mealtime Ultra-Rapid Acting Insulin (Afrezza) in Uncontrolled Type 2 Diabetes Patients Start of enrollment: 2017 Oct 16
Publications & Presentations
PubMed
- 7 citationsModel for Integration of Monogenic Diabetes Diagnosis Into Routine Care: The Personalized Diabetes Medicine Program.Haichen Zhang, Jeffrey W Kleinberger, Kristin A Maloney, Yue Guan, Trevor J Mathias
Diabetes Care. 2022-08-01 - 11 citationsUltra Rapid-Acting Inhaled Insulin Improves Glucose Control in Patients With Type 2 Diabetes MellitusPhilip Levin, Byron J. Hoogwerf, Janet K. Snell-Bergeon, Tim Vigers, Laura Pyle
Endocrine Practice. 2020-12-14 - 4 citationsPREDICTORS AND CLINICAL OUTCOMES OF TREATMENT INTENSIFICATION IN PATIENTS WITH TYPE 2 DIABETES UNCONTROLLED ON BASAL INSULIN IN A REAL-WORLD SETTINGLee Kallenbach, Amy Shui, Wendy Y. Cheng, Tao Fan, Wenli Hu
Endocrine Practice. 2018-07-05
Press Mentions
- MannKind Presents Novel Scientific Data at 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020)February 20th, 2020
- MannKind Presents Positive Afrezza® Clinical Data from Three Studies at ADA 79th Scientific SessionsJune 9th, 2019
- Digital Health Start-up Amalgam Rx Launches with Insulin Titration AppMay 1st, 2017
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: